HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidenori Suzuki Selected Research

GR 82334

10/2011Intra-articular administration of tachykinin NK₁ receptor antagonists reduces hyperalgesia and cartilage destruction in the inflammatory joint in rats with adjuvant-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidenori Suzuki Research Topics

Disease

75Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
03/2022 - 12/2003
40Brain Injuries (Brain Injury)
03/2022 - 04/2009
30Neoplasms (Cancer)
08/2022 - 11/2008
30Brain Edema (Cerebral Edema)
01/2021 - 04/2009
22Intracranial Vasospasm
01/2020 - 12/2003
18Neuralgia (Stump Neuralgia)
06/2021 - 03/2003
18Pain (Aches)
01/2021 - 08/2002
15Aneurysm (Aneurysms)
01/2021 - 01/2011
13Hyperalgesia
01/2021 - 11/2004
13Inflammation (Inflammations)
01/2020 - 11/2004
11Thrombosis (Thrombus)
10/2022 - 06/2003
11Spinal Cord Injuries (Spinal Cord Injury)
12/2021 - 09/2009
11Squamous Cell Carcinoma of Head and Neck
07/2021 - 06/2007
10Brain Ischemia (Cerebral Ischemia)
03/2022 - 01/2011
9Hemorrhage
01/2022 - 08/2008
7Spinal Cord Diseases
04/2022 - 08/2014
7Rupture
01/2020 - 01/2011
6Hydrocephalus (Hydrocephaly)
03/2022 - 09/2006
6Head and Neck Neoplasms (Head and Neck Cancer)
03/2022 - 02/2015
6Carcinoma (Carcinomatosis)
11/2021 - 09/2007
6Intracranial Aneurysm (Cerebral Aneurysm)
01/2020 - 06/2012
6Cerebral Infarction
01/2020 - 01/2015
6Herpes Zoster
02/2019 - 12/2009
6Atopic Dermatitis (Atopic Eczema)
03/2014 - 01/2007
5Wounds and Injuries (Trauma)
10/2022 - 01/2015
5Carotid Stenosis (Carotid Artery Stenosis)
12/2021 - 12/2014
5Neoplasm Metastasis (Metastasis)
07/2021 - 08/2014
5Body Weight (Weight, Body)
12/2020 - 02/2010
5Schizophrenia (Dementia Praecox)
10/2018 - 04/2008
5Hypersensitivity (Allergy)
03/2014 - 12/2008
4Hematoma
05/2022 - 01/2011
4Ischemia
03/2022 - 03/2011
4Stroke (Strokes)
01/2022 - 09/2017
4Pathologic Constriction (Stenosis)
12/2021 - 10/2017
4Neuroinflammatory Diseases
07/2020 - 02/2017
4Muscle Spasticity (Spastic)
01/2020 - 11/2010
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2018 - 11/2008
4Chronic Pain
01/2015 - 01/2008
4Mental Disorders (Mental Disorder)
08/2014 - 06/2008
3Ischemic Stroke
10/2022 - 02/2010
3Paralysis (Palsy)
05/2022 - 05/2017

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2003
27TenascinIBA
01/2020 - 05/2008
15OsteopontinIBA
03/2022 - 03/2009
12Biomarkers (Surrogate Marker)IBA
04/2021 - 10/2011
9MicroRNAs (MicroRNA)IBA
04/2021 - 05/2013
9Pharmaceutical PreparationsIBA
09/2017 - 08/2002
8Mitogen-Activated Protein KinasesIBA
07/2020 - 01/2011
8Toll-Like Receptor 4IBA
01/2020 - 02/2017
7PlatinumIBA
07/2021 - 10/2014
7PeriostinIBA
01/2021 - 01/2017
7Analgesics (Analgesic Drugs)IBA
03/2020 - 01/2008
7Galectin 3 (LGALS3)IBA
01/2020 - 01/2018
6CytokinesIBA
12/2021 - 11/2008
6EnzymesIBA
01/2021 - 12/2003
6Matrix Metalloproteinases (MMPs)IBA
01/2021 - 12/2009
6CollagenIBA
02/2020 - 12/2003
6Phosphotransferases (Kinase)IBA
01/2020 - 02/2011
6Immunoglobulin E (IgE)IBA
03/2014 - 08/2005
6Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
11/2011 - 03/2003
5Neuroprotective AgentsIBA
03/2022 - 02/2010
5salicylhydroxamic acid (SHAM)IBA
02/2020 - 02/2010
5Indicators and Reagents (Reagents)IBA
04/2018 - 03/2009
5AntigensIBA
01/2015 - 08/2005
41- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA
12/2021 - 02/2015
4LigandsIBA
01/2021 - 02/2017
4IsofluraneFDA LinkGeneric
10/2020 - 06/2012
4Caspase 3 (Caspase-3)IBA
10/2020 - 12/2009
4Fibrinogen (Factor I)FDA Link
01/2020 - 02/2015
4Cilostazol (Pletal)FDA LinkGeneric
01/2020 - 10/2008
4Heme (Haem)IBA
01/2020 - 12/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019 - 09/2012
4Tight Junction ProteinsIBA
07/2019 - 02/2010
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2019 - 02/2010
4Therapeutic UsesIBA
01/2019 - 04/2012
4Coloring Agents (Dyes)IBA
04/2018 - 05/2009
4Hemostatics (Antihemorrhagics)IBA
05/2017 - 08/2008
4Phosphates (Orthophosphate)IBA
06/2016 - 03/2013
4Imatinib Mesylate (Gleevec)FDA Link
01/2015 - 04/2012
4Collagenases (Collagenase)FDA Link
02/2013 - 01/2011
4Substance PIBA
10/2011 - 01/2007
4Tachykinin Receptors (Tachykinin Receptor)IBA
10/2011 - 08/2002
4Nerve Growth Factor (NGF)IBA
01/2011 - 03/2003
4Glycoproteins (Glycoprotein)IBA
01/2011 - 05/2008
4(1-6)-alpha-glucomannan (glucomannan)IBA
01/2010 - 01/2007

Therapy/Procedure

25Therapeutics
10/2021 - 03/2003
10Radiotherapy
03/2022 - 06/2007
9Chemoradiotherapy
03/2022 - 08/2014
7Neck Dissection (Radical Neck Dissection)
08/2022 - 08/2014
6Laminectomy
01/2021 - 11/2013
5Stents
10/2022 - 01/2013
5Laminoplasty
04/2022 - 08/2014
5Drug Therapy (Chemotherapy)
07/2021 - 06/2007
5Ligation
06/2021 - 03/2011
5Decompression
01/2017 - 08/2012
4Free Tissue Flaps
03/2022 - 10/2017
4Analgesia
03/2020 - 04/2007
4Surgical Instruments (Clip)
01/2018 - 01/2011
4Craniotomy
01/2018 - 01/2011
3Catheters
10/2022 - 01/2016